Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06603324
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-02-22
Brief Title:
Analysis of Paediatric Treatments with MultiFiltratePRO
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Efficacy and Safety of Paediatric CVVHD Treatment with MultiFiltratePRO a Prospective Multicenter Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ECHOped
Brief Summary:
This clinical study evaluates the performance of the MultifiltratePro in pediatric mode for Continuous Venovenous Hemodiafiltration CVVHD in children Its primary aim is to assess the efficacy of the MultifiltratePro in paediatric mode specifically in achieving at least 80 of the prescribed effluent dose within 72 hours Additionally the study focuses on the safety of this mode in a paediatric setting closely monitoring for clinical adverse events hemodynamic instability and electrolyte imbalances Paediatric patients with body weights between 8kg and 40kg will be treated with the MultifiltratePro for a period of up to 10 days with the treatment duration and approach being tailored to the severity of each patients condition
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None